Vertex logo

Vertex

VERX | NASDAQ
Chart Builder DCF Calculator
$18.40
+$0.43 (+2.39%)
At close: Nov 16, 2026, 4:00 PM ET
$18.14
-$0.26 (-1.41%)
After-hours: Nov 16, 2026, 7:30 PM ET
+2.39%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
27.2
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #750/817 (Top 92%)

Key Statistics

Market Data

Market Cap $2.99B
1D Range
17.84 18.57
52W Range
10.58 20.62

Valuation (TTM)

PE -65.71
PB 16.57
EV/EBITDA 57.51

Valuation (NTM)

Forward PE 21.14
Forward PEG -1.94
Price Target $16.50
Loading financial charts...

Profile

Vertex, Inc. specializes in delivering advanced tax technology solutions to corporations across various sectors, including retail, communication, leasing, and manufacturing. These services are provide...

Sector Technology
Employees 2,000
IPO Date Jul 29, 2020
Fiscal Year January - December

Latest News

Vertex Pharmaceuticals Prepares for Key Kidney Drug Decision as Pipeline Readouts Loom

19 hours ago · marketbeat.com

Vertex Pharmaceuticals Prepares for Key Kidney Drug Decision as Pipeline Readouts Loom
Maze Therapeutics: Vertex Is Building The Road, And Maze Gets To Drive On It

3 days ago · seekingalpha.com

Maze Therapeutics: Vertex Is Building The Road, And Maze Gets To Drive On It
BioNTech vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?

5 days ago · fool.com

BioNTech vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
Only One in Six Enterprises Treats Indirect Tax as a Standing Board Item

6 days ago · globenewswire.com

Only One in Six Enterprises Treats Indirect Tax as a Standing Board Item
Here is Why Growth Investors Should Buy Vertex (VERX) Now

8 days ago · zacks.com

Here is Why Growth Investors Should Buy Vertex (VERX) Now
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?

10 days ago · fool.com

Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?
Prediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 Years

11 days ago · fool.com

Prediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 Years
What Vertex (VERX) Said on Its Q3 Earnings Call

12 days ago · marketbeat.com

What Vertex (VERX) Said on Its Q3 Earnings Call
Vertex, Inc. (VERX) Q3 2026 Earnings Call Transcript

12 days ago · seekingalpha.com

Vertex, Inc. (VERX) Q3 2026 Earnings Call Transcript
Vertex (VERX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

12 days ago · zacks.com

Vertex (VERX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.26
Beat +16.96%
REV
$213.28M
Beat +1.69%
Next Earnings
Feb 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
11
Consensus
Buy
Price Target
$16.50
Downside
-10.33%
Buy (6)
Hold (5)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.